Skip to main content

Advertisement

Table 3 Classification of the F 2 siblings obtained from Crosses I and II

From: Reassessment of the function of somatolactin alpha in lipid metabolism using medaka mutant and transgenic strains

Genotypes of the Cross I siblings Phenotypes of the siblings*
[Ci/Ci; B/b; R/r; SLa+/SLa], [Ci/ci; B/b; R/r; SLa+/SLa] black, orange, SLa++
[Ci/Ci; B/b; R/r; SLa/SLa], [Ci/ci; B/b; R/r; SLa/SLa] black, orange, SLa+
[Ci/Ci; B/b; r/r; SLa+/SLa], [Ci/ci; B/b; r/r; SLa+/SLa] black, SLa++
[Ci/Ci; B/b; r/r; SLa/SLa], [Ci/ci; B/b; r/r; SLa/SLa] black, SLa+
[Ci/Ci; b/b; R/r; SLa+/SLa], [Ci/ci; b/b; R/r; SLa+/SLa] orange, SLa++
[Ci/Ci; b/b; R/r; SLa/SLa], [Ci/ci; b/b; R/r; SLa/SLa] orange, SLa+
[Ci/Ci; b/b; r/r; SLa+/SLa], [Ci/ci; b/b; r/r; SLa+/SLa] SLa++
[Ci/Ci; b/b; r/r; SLa/SLa], [Ci/ci; b/b; r/r; SLa/SLa] SLa+
Genotypes of the Cross II siblings Phenotypes of the siblings*
[Ci/ci; B/B; R/R; SLa+/SLa], [Ci/ci; B/B; R/r; SLa+/SLa], black, orange, SLa++
[Ci/ci; B/b; R/R; SLa+/SLa], [Ci/ci; B/b; R/r; SLa+/SLa],
[ci/ci; B/B; R/R; SLa+/SLa], [ci/ci; B/B; R/r; SLa+/SLa],
[ci/ci; B/b; R/R; SLa+/SLa], [ci/ci; B/b; R/r; SLa+/SLa]
[Ci/ci; B/B; R/R; SLa/SLa], [Ci/ci; B/B; R/r; SLa/SLa], black, orange, SLa+
[Ci/ci; B/b; R/R; SLa/SLa], [Ci/ci; B/b; R/r; SLa/SLa]
[ci/ci; B/B; R/R; SLa/SLa], [ci/ci; B/B; R/r; SLa/SLa], black, orange, SLa
[ci/ci; B/b; R/R; SLa/SLa], [ci/ci; B/b; R/r; SLa/SLa]  
  1. *: SLa++ overexpression, SLa+ normal expression, SLa no expression. SLa expression from the wild-type Ci allele is negligible when the exogenous SLa gene is present.